Sen. Max Baucus: Answer 10 Questions About Mandatory Purchase of Health Insurance Including Why the Public Was Excluded From Today's Committ... ( WASHINGTON May 14 -- The U....)

HOME >> MEDICINE >> NEWS

Sen. Max Baucus: Answer 10 Questions About Mandatory Purchase of Health Insurance Including Why the Public Was Excluded From Today's Committee Meeting

Date:5/14/2009

WASHINGTON, May 14 /PRNewswire-USNewswire/ -- The U.S. Senate Finance Committee, in closed-door health care discussions today, must answer ten questions about how its plan to require all Americans to show proof of insurance or face tax penalties will provide affordable health care, said Consumer Watchdog.

Questions listed below. Download Consumer Watchdog's letter to Senator Baucus here: http://www.ConsumerWatchdog.org/resources/BaucusClosedMeeting.pdf

In a letter to Senator Baucus sent today, Consumer Watchdog wrote:

"Americans should not be locked out of any discussion about health care reform, particularly one that will consider whether everyone should be required to buy health insurance policies without any limits on what insurers can charge. Mandatory purchases of private insurance policies without offering a public alternative to the private market is nothing other than a bailout for HMOs -- whose greed, waste and indifference to our health have created the current mess.

"There's no mention of cost-cutting in the Senate Finance Committee's 'policy options' document being discussed in today's closed meeting -- no regulation of HMO premiums, no limits on how much consumers will have to pay out of their own pocket in co-pays or deductibles."

Earlier this week, the Senate Finance Committee circulated a "policy options" white paper to be discussed in today's meeting, which excludes members of the media and public. The senate finance document makes the president's promised "public option" to the private insurance market optional, and does not include cost controls.

Senator Max Baucus (D-MT), chairman of the Senate Finance Committee, has receiv
'/>"/>

SOURCE Consumer Watchdog
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5
Related medicine news :

1. President Obama, Sens. Kennedy & Baucus: Dont Buy Insurer Compromise for Bush-era Plan to Gut State Consumer Protection Laws
2. Heinz Family Philanthropies (www.heinzfamily.org) Release New Facts About Cards, Highlighting Questions Families Should Ask About Long-Term Care -- 10 Questions to Answer... (www.tenquestionstoanswer.org)
3. Taking Control of Your Diabetes Conference Returns to Indianapolis to Bring Answers, Advocacy and Hope for People With Diabetes
4. Taking Control of Your Diabetes Conference Returns to Raleigh to Bring Answers, Advocacy and Hope for People With Diabetes
5. Video: New First Response(R) Fertility Test Helps Women Answer the Question: Am I Able to Get Pregnant?
6. Answers for Life: Siemens Latest Cutting-Edge Health IT Technology Takes Center Stage at HIMSS 2009
7. Keeping nurses on the job: Retention is part of the answer to the nursing shortage
8. ZEO Health's New Program Offers Answer for Those Looking for Income
9. As the Number of Unemployed Grows, Pfizer Helpful Answers and SABEResPODER Join Forces to Educate Hispanics Who Lack Health Insurance About How to Access Prescription Medicines
10. COBRA-Answers.com Addresses Consumer Concerns Over COBRA Legislation
11. Could This Be The Answer To The Obesity Epidemic?

Post Your Comments:

(Date:5/24/2013)... NY (PRWEB) May 24, 2013 ... (AICASA) has signed an articulation agreement with ... students to study abroad in Antigua. , ... college credits after participating in a cell biology course, ... articulation agreement with American University of Antigua (AUA) ...

(Date:5/24/2013)... (PRWEB) May 24, 2013 The ... of products used outside the central laboratory, by ... a healthcare practitioner or by consumers. This includes ... fertility and pregnancy, infectious and cardiovascular disease and ... such as critical care, surgical and emergency departments. ...

(Date:5/24/2013)... than half of recommended well-child visits had up to ... attended most of their visits, according to a study ... Care . The study included more than 20,000 children ... chronic conditions like asthma and heart disease were even ... according to the study. In fact, children with ...

(Date:5/24/2013)... is available in German . ... "alpha-synuclein" aggregates and accumulates within neurons. Specific areas of ... and advances. The mechanism underlying this pathological progression is ... protein (or abnormal forms of it) along nerve projections ... the German Center for Neurodegenerative Diseases (DZNE) in Bonn ...

(Date:5/24/2013)... presented today shows that formation of new neurons in ... importance in learning and remembering - could cause forgetting ... brain circuits. Drs. Paul Frankland and Sheena Josselyn, ... argue this reorganization could have the positive effect of ... for new learning. These results were presented at ...

Breaking Medicine News(10 mins):Health News:AICASA Signs Articulation Agreement with Old Dominion University to Create Study Abroad Program 2 Health News:Point of Care Diagnostics Market (POC) Analysis and 5 Year Forecast in New Research Report at ReportsnReports.com 2 Health News:Point of Care Diagnostics Market (POC) Analysis and 5 Year Forecast in New Research Report at ReportsnReports.com 3 Health News:Young children who miss well-child visits are more likely to be hospitalized 2 Health News:Young children who miss well-child visits are more likely to be hospitalized 3 Health News:Proteins in migration 2 Health News:Proteins in migration 3 Health News:Proteins in migration 4 Health News:New neuron formation could increase capacity for new learning, at the expense of old memories 2

[0] AICASA Signs Articulation Agreement with Old Dominion University to Create Study Abroad Program [0] Point of Care Diagnostics Market (POC) Analysis and 5 Year Forecast in New Research Report at ReportsnReports.com [0] Young children who miss well-child visits are more likely to be hospitalized [0] Proteins in migration [0] New neuron formation could increase capacity for new learning, at the expense of old memories

... the 13th time, more than any hospital in the U.S. , ... ... (NorthShore) was named one of the nation,s 100 Top Hospitals® by Thomson ... and quality of healthcare. NorthShore has been named a Top 100 Hospital ...

... (April 1, 2009) It appears that a drug ... similar effect on the compulsive behavior of kleptomaniacs it ... the University of Minnesota., The Medical School,s Department of Psychiatry ... ages 17-75, who spent an average of at least one ...

... KUALA LUMPUR, Malaysia, March 31 Rheumatoid arthritis (RA) ... which the body,s defense system attacks the joints through ... lines and lubricates the joints. The most visible symptoms ... of the hands and feet. It can cause fatigue, ...

... LifeCare Holdings, Inc. (the "Company") today announced its operating ... 2008. Three Months Ended December 31, 2008 ... service revenue of $94.2 million for the three months ended ... the same period in 2007 while patient days were unchanged. ...

... Guideline Reached For Quantitative Polymerase Chain ReactionSALT LAKE CITY, ... and the American Association for Clinical Chemistry ... for a key laboratory method called qPCR (or quantitative ... international scientists representing the medical and research fields. qPCR ...

... The U.S. District Court for the District of ... between Alza Corporation, McNeil-PPC, Inc. and Andrx Pharmaceuticals LLC. ... markets CONCERTA(R) (methylphenidate HCI) Extended-Release Tablets CII, said the ... valid or infringed by the filing of Andrx,s Abbreviated ...

NorthShore University HealthSystem Named One of the Nation's Top 100 Hospitals by Thomson Reuters Drug commonly used for alcoholism, drug addiction, curbs urges of compulsive stealers Frost & Sullivan: Rheumatoid Arthritis Therapeutics in Malaysia LifeCare Holdings, Inc. Announces Year-End Results International Scientists Secure Quality in Molecular Diagnostics District Court Decision Received in CONCERTA(R) Patent Case

(Date:5/24/2013)... LOS ANGELES , May 24, 2013 An ... gathered on Saturday, May 18, in Santa ... findings on new lung-sparing therapies for MPM, a rare ... and commonly affects the pleura, the lining of the ... Heart, Lung and Blood Institute, the 3rd Annual International ...

(Date:5/24/2013)... May 24, 2013 In accordance with Rule 17.1 ... 14e-1 of the United States Exchange Act, Echo Pharma Acquisition ... for Elan Corporation (NYSE: ELN). Background ... made an offer for the entire of the issued and ... (the "Original Offer"). On 20 May 2013, ...

(Date:5/23/2013)... 24, 2013 3SBio Inc. (NASDAQ: ... leading China -based biotechnology company ... products, announced today that, at an extraordinary general ... voted in favor of the proposal to authorize ... of merger dated February 8, 2013, among Decade ...

Breaking Medicine Technology:International Mesothelioma Experts Present Promising New Research Findings at the 3rd Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma 2 International Mesothelioma Experts Present Promising New Research Findings at the 3rd Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma 3 Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 2 Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 3 Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 4 Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 5 Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 6 Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 7 Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 8 Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 9 3SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 2 3SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 3

[0] International Mesothelioma Experts Present Promising New Research Findings at the 3rd Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma [0] Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements [0] 3SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement

... 16, 2011 Cancer patients in China ... the announcement that a leading cancer center is acquiring ... VAR). This device is the first high dose rate ... leader in radiotherapy systems. Jilin University ...

... 16, 2011 U L ... announced today that it has filed an abbreviated 510(k) application ... label claim to include the management and mitigation of pain. ... a randomized clinical study comparing Altrazeal® to Acquacel® Ag in ...

Cached Medicine Technology:First Varian High Dose Rate Brachytherapy Afterloader Supplied to Leading China Cancer Hospital 2 ULURU Inc. Announces the Filing of a 510(k) Application to Expand Altrazeal®'s Label Claim 2 ULURU Inc. Announces the Filing of a 510(k) Application to Expand Altrazeal®'s Label Claim 3 ULURU Inc. Announces the Filing of a 510(k) Application to Expand Altrazeal®'s Label Claim 4

First Varian High Dose Rate Brachytherapy Afterloader Supplied to Leading China Cancer Hospital ULURU Inc. Announces the Filing of a 510(k) Application to Expand Altrazeal®'s Label Claim

VascoTip is a unipolar tined permanent pacing lead. Due to advanced technology, VascoTip 9/60 M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm), 5 mm, 6 mm....

VascoScrew is a unipolar permanent pacing lead with a fixed screw a double flanch for permanent pacing. Due to latest technologies, VascoScrew D10/60 M is compatible to all pacemaker-cavities with th...

VascoTwist is a low profile unipolar permanent pacing lead with a retractable screw. Due to advanced technology VascoTwist 9/60 M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm...

VascoScrew is a low profile unipolar pacing lead with a fixed screw for permanent pacing. Due to latest technologies, VascoScrew 6/60 M is compatible to all pacemaker-cavities with the size of IS-1 (...

Medicine Products:

VascoTip CC 9/60 M VascoScrew E D10/60 M VascoTwist CC 9/60 S VascoScrew P 8/60 S